Drug General Information
Drug ID	D05RZE
Former ID	DIB003702
Drug Name	LY-2623091
Synonyms	Chronic renal disease therapy, Eli Lilly
Indication	Chronic kidney disease [ICD9: 403, 585.1-585.5, 585.9; ICD10:N18]		Phase 2	[524840]
Company	Eli Lilly & Co
Structure		Download 2D MOL 3D MOL
Target and Pathway
Target(s)	Mineralocorticoid receptor	Target Info	Antagonist	[533270]
KEGG Pathway	Aldosterone-regulated sodium reabsorption
PathWhiz Pathway	Kidney Function
WikiPathways	ACE Inhibitor Pathway
References
Ref 524840	ClinicalTrials.gov (NCT02194465) A Study of LY2623091 in Participants With High Blood Pressure. U.S. National Institutes of Health.
Ref 533270	Nonsteroidal antagonists of the mineralocorticoid receptor. Curr Opin Nephrol Hypertens. 2015 Sep;24(5):417-24.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.